About Purple Squirrel
Purple Squirrel is a Healthcare company based in New York (United States) founded in 2016 by Gabriel Tremblay and Anna Forsythe, and was acquired by Cytel in December 2020. Provider of market access services to biopharma sector. Its chief executive, as recorded, is Anna Forsythe. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and Hylant; 1 of its 3 listed competitors has raised funding.
Company details
Purple Squirrel, established in 2016 and currently in Acquired stage, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access services to biopharma sector. Adapting to market demands with innovation and client-focused strategies.
- Headquarters New York, United States
- Founders Gabriel Tremblay, Anna Forsythe
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website purplesquirreleconomics.com
- Social LinkedIn X Facebook
- Acquired by Cytel (Dec 2020)
Investors in Purple Squirrel
Purple Squirrel has secured backing from 1 investor. Prominent investors backing the company include Cytel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Data analysis and statistical solutions are provided for life sciences. | 1987 | cytel.com | Cambridge, United States |
Investor details for Purple Squirrel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Purple Squirrel
2 people are tracked at Purple Squirrel (2 in leadership).
| Name | Role | Group |
|---|---|---|
Gabriel Tremblay | Founder | Leadership |
Anna Forsythe | Founder & CEO | Leadership |
Complete people profiles for Purple Squirrel
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Purple Squirrel
2 dated milestones of Purple Squirrel across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Purple Squirrel is founded.
- Exit Acquired by Cytel.
Competitors of Purple Squirrel
Purple Squirrel has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and Hylant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| hylant.com | 1935 | Toledo, United States | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. |
Detailed competitors of Purple Squirrel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Purple Squirrel (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Purple Squirrel
Purple Squirrel was founded in 2016.
Purple Squirrel is headquartered in New York, United States. It is registered at New York, New York, United States.
Anna Forsythe is the CEO of Purple Squirrel, as recorded in our data. They have also founded this company.
Purple Squirrel, established in 2016 and currently in Acquired stage, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access services to biopharma sector. Adapting to market demands with innovation and client-focused strategies.
Purple Squirrel's top competitors include Target RWE, Secura Bio and Hylant.
Purple Squirrel has 1 investor. Key investors include Cytel.
Yes. Purple Squirrel was acquired by Cytel in December 2020.